# FDA Inspection 1220167 - Rui-Hua Xu, MD, PhD - September 04, 2023

Source: https://www.keypedia.com/records/fda_inspections/rui-hua-xu-md-phd/ce505250-48da-4de2-ab90-16bce538939c
Source feed: FDA_Inspections

> FDA Inspection 1220167 for Rui-Hua Xu, MD, PhD on September 04, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220167
- Company Name: Rui-Hua Xu, MD, PhD
- Inspection Date: 2023-09-04
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1254979 - 2024-11-08](https://www.keypedia.com/records/fda_inspections/rui-hua-xu-md-phd/638b1b8c-075a-4f4f-8207-45b41e43126e)
- [FDA Inspection 1254979 - 2024-11-08](https://www.keypedia.com/records/fda_inspections/rui-hua-xu-md-phd/e404248b-23c5-4868-967f-935a78cf9570)

Company: https://www.keypedia.com/companies/rui-hua-xu-md-phd/a35204bb-cf25-4537-974d-54f707f408ea

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c